Search Within

Wassim Abida

Formats
  1. Meeting Abstract (75)
  2. Journal Article (69)
  3. Editorial (4)
  4. Research Letter (2)
  5. Review (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (154)
  2. Genitourinary Oncology Service (154)
  3. Solid Tumor Oncology Division (154)
  4. GSK Faculty (71)
  5. Human Oncology and Pathogenesis Program (67)
  6. Sloan Kettering Institute Postdocs (57)

More Groups

People
  1. Howard Scher (68)
  2. Michael Morris (38)
  3. David Solit (36)
  4. Nikolaus Schultz (32)
  5. Anuradha Gopalan (31)
  6. Dana Rathkopf (31)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (14)
  4. 2022 (15)
  5. 2021 (19)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Clinical Cancer Research (15)
  3. Annals of Oncology (13)
  4. Cancer Research (13)
  5. European Urology (8)
  6. JCO Precision Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (44)
  2. American Association for Cancer Research (31)
  3. Nature Publishing Group (15)
  4. Oxford University Press (13)
  5. Elsevier Science, Inc. (10)
  6. Nature Research (5)

More Publishers

Results (154)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses
    Meeting Abstract

    Abida, W.; Campbell, D.; Patnaik, A.; Sautois, B.; Shapiro, J.; Vogelzang, N. J.; Bryce, A. H.; McDermott, R.; Ricci, F.; Rowe, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Comparison of magnetic resonance imaging-stratified clinical pathways and systematic transrectal ultrasound-guided biopsy pathway for the detection of clinically significant prostate cancer: A systematic review and meta-analysis of randomized controlled trials
    Review

    Woo, S.; Suh, C. H.; Eastham, J. A.; Zelefsky, M. J.; Morris, M. J.; Abida, W.; Scher, H. I.; Sidlow, R.; Becker, A. S.; Wibmer, A. G.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • IMPACT: Immunotherapy in patients with metastatic cancers and CDK12 mutations
    Meeting Abstract

    Reimers, M. A.; Abida, W.; Chou, J.; George, D. J.; Heath, E. I.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; Choi, J. E.; Feng, F. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes
    Meeting Abstract

    Mota, J. M.; Barnett, E.; Nauseef, J.; Stopsack, K. H.; Wibmer, A. G.; Danila, D. C.; Rathkopf, D. E.; Slovin, S. F.; Kantoff, P. W.; Scher, H. I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients
    Meeting Abstract

    McBride, S. M.; Zelefsky, M. J.; Spratt, D. E.; Paller, C. J.; Kollmeier, M.; Slovin, S. F.; Aghalar, J.; Hearn, J. W. D.; Den, R. B.; Deville, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2
    Meeting Abstract

    Abida, W.; Bryce, A. H.; Vogelzang, N. J.; Amato, R. J.; Percent, I. J.; Shapiro, J. D.; McDermott, R. S.; Hussain, A.; Patnaik, A.; Petrylak, D. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic characterization of parenchymal brain metastases (BM) in prostate cancer (PCa)
    Meeting Abstract

    Mota, J. M. S. C.; Teo, M. Y.; Knezevic, A.; Bambury, R. M.; Hatzoglou, V.; Autio, K. A.; Abida, W.; Gopalan, A.; Fine, S.; Danila, D. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor testing in men with prostate cancer to predict for germline DNA-damage repair mutations
    Meeting Abstract

    Carlo, M. I.; Kemel, Y.; Breen, K.; Cadoo, K. A.; Walsh, M. F.; Abida, W.; Autio, K. A.; Danila, D. C.; Kampel, L. J.; Morris, M. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Karthaus, W.; Mota, J. M.; Mu, P.; Wu, C.; Abida, W.; Linton, E.; Lee, Y. S.; Lee, E.; Mao, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save